Evidence map›Paper›PMID 39766318›Full record

ArticleBiomolecules2024

A Novel Ginsenoside-Transforming α-L-Rhamnosidase from

Chang-Hao Cui, Doohang Shin, Byung-Serk Hurh, Wan-Taek Im

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chang-Hao CuiSempio Fermentation Research Center, Sempio Foods Company, Osong 28156, Republic of Korea.
Doohang ShinSempio Fermentation Research Center, Sempio Foods Company, Osong 28156, Republic of Korea.
Byung-Serk HurhSempio Fermentation Research Center, Sempio Foods Company, Osong 28156, Republic of Korea.
Wan-Taek ImDepartment of Biotechnology, Hankyong National University, Anseong 17579, Republic of Korea.

Funding

Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries 321038-5
6 · The paper itself

Abstract

Despite the rapid advancement of glycosidase biotechnology, ginsenoside-transforming rhamnosidases remain underexplored due to a lack of research. In this study, we aimed to bridge this gap by evaluating eight putative rhamnosidases for their ability to transform ginsenosides. Among them, a novel rhamnosidase (C118) from

Indexed as

BifidobacteriumGinsenosidesGlycoside HydrolasesEscherichia coliHydrogen-Ion ConcentrationHydrolysisKineticsSubstrate Specificityalpha-L-rhamnosidaseGinsenosidesGlycoside Hydrolasesbiotransformationginsenosideginsenoside Reginsenoside Rg1α-L-rhamnosidase

Identifiers

PMID39766318
PMCPMC11673932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.